Gossamer Bio, Inc.
GOSS
$1.45
$0.1511.54%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | 105.32M | 95.84M | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 105.32M | 95.84M | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | 105.32M | 95.84M | -- | -- | -- |
SG&A Expenses | 35.80M | 36.58M | 37.89M | 38.46M | 42.23M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 168.14M | 165.23M | 167.76M | 173.73M | 189.04M |
Operating Income | -62.82M | -69.39M | -167.76M | -173.73M | -189.04M |
Income Before Tax | -68.34M | -76.42M | -172.58M | -179.82M | -187.43M |
Income Tax Expenses | 3.30M | 4.44M | -- | -- | -- |
Earnings from Continuing Operations | -71.65 | -80.85 | -172.58 | -179.82 | -187.43 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -71.65M | -80.85M | -172.58M | -179.82M | -187.43M |
EBIT | -62.82M | -69.39M | -167.76M | -173.73M | -189.04M |
EBITDA | -61.80M | -68.20M | -166.36M | -172.12M | -187.27M |
EPS Basic | -0.32 | -0.39 | -1.05 | -1.38 | -1.76 |
Normalized Basic EPS | -0.20 | -0.24 | -0.66 | -0.87 | -1.12 |
EPS Diluted | -0.32 | -0.39 | -1.06 | -1.39 | -1.77 |
Normalized Diluted EPS | -0.20 | -0.25 | -0.66 | -0.87 | -1.12 |
Average Basic Shares Outstanding | 903.71M | 870.25M | 739.47M | 608.61M | 477.48M |
Average Diluted Shares Outstanding | 916.03M | 882.57M | 739.47M | 608.61M | 477.48M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |